Pharmacotherapy is an essential component of obesity treatment, as well as efforts focused on changing the lifestyle, correcting the food consumption and increasing the physical activity. The administration of central-acting drugs as pharmacotherapy of obesity is pathogenetically justified and allows improving the effectiveness of treatment.
In this article, the use of sibutramine, a serotonin and norepinephrine reuptake inhibitor, is considered in various aspects of endocrinologist’s practice. In addition to aforesaid there is an application of a specific clinical observation. Logvinova Endocrinology Research Centre Author for correspondence. Email: ORCID iD: SPIN-code: Russian Federation, Dmitriya Ulyanova st., 11, Moscow, Russia, 117036 post-graduate student of the department of therapeutic endocrinology Marina O. Galieva Endocrinology Research Centre Email: ORCID iD: SPIN-code: Russian Federation, Dmitriya Ulyanova st., 11, Moscow, Russia, 117036 post-graduate student of the department of therapeutic endocrinology Natalia V. Mazurina Endocrinology Research Centre Email: ORCID iD: SPIN-code: Russian Federation, Dmitriya Ulyanova st., 11, Moscow, Russia, 117036 PhD, leading researcher Ekaterina A.
Oct 10, 2018 - These perceptions are supported by numerous studies on the power of yogic breathing techniques on anxiety and control in individuals with.
Troshina Endocrinology Research Centre Email: SPIN-code: Russian Federation, Dmitriya Ulyanova st., 11, Moscow, Russia, 117036 MD, Prof., corresponding member of the RAS. Pembiasan gelombang.